Debora Fumagalli
5PUBLICATIONS
53CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 22, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi
|Jul 29, 2021
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.David Venet, Mattia Rediti, Marion Maetens
|Jun 29, 2021
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum
|Feb 04, 2021
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.Martine Piccart, Marion Procter, Debora Fumagalli
|Oct 18, 2019
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.Rina Hui, Alex Pearson, Javier Cortes
Pageof 1
Frequent Collaborators
4 joint publications
Evandro de Azambuja
3 joint publications
Nadia Harbeck
3 joint publications
Christos Sotiriou
3 joint publications
Sherene Loi
2 joint publications
David Venet
2 joint publications
Paolo Nuciforo
2 joint publications
Philippe L Bedard
2 joint publications
Giuseppe Curigliano
2 joint publications
Martine Piccart
2 joint publications
Marco Colleoni
